AMGN - AMGEN INC
IEX Last Trade
261.22
-0.290 -0.111%
Share volume: 66,235
Last Updated: Fri 10 Jan 2025 08:29:53 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$261.51
-0.29
-0.11%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-02 | 2023-08-03 | 2023-10-31 | 2024-10-30 | 2024-05-02 | 2024-08-06 | 2024-10-30 | |
| Cash flow financing | 21.509 B | -1.210 B | -2.005 B | 2.754 B | -1.708 B | -2.649 B | -3.651 B | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 23.931 B | 2.688 B | 493.000 M | -23.797 B | -1.236 B | -407.000 M | -290.000 M | |
| Net income | 2.841 B | 1.379 B | 1.730 B | 767.000 M | -113.000 M | 746.000 M | 2.830 B | |
| Depreciation | 900.000 M | 896.000 M | 895.000 M | 1.380 B | 1.399 B | 1.400 B | 1.396 B | |
| Changes in inventories | 58.000 M | 0.000 | 0.000 | 0.000 | -806.000 M | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 1.358 B | -211.000 M | -262.000 M | -27.089 B | -217.000 M | -217.000 M | -210.000 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 28.000 M | 59.000 M | -14.000 M | 151.000 M | 13.000 M | 21.000 M | 47.000 M | |
| Dividends Paid | -1.137 B | -1.139 B | -1.140 B | -1.140 B | -1.208 B | -1.209 B | -1.210 B | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 344.000 M | 271.000 M | 248.000 M | 249.000 M | 230.000 M | 238.000 M | 257.000 M | |
| Cash Change | 23.931 B | 2.688 B | 493.000 M | -23.797 B | -1.236 B | -407.000 M | -290.000 M |